Advertisement
Screener

TFF PHARMACEUTICALS, INC. Form PRE 14A: Preliminary proxy statement

TFF PHARMACEUTICALS, INC. Form PRE 14A: Preliminary proxy statement

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2024-12-11: Form PRE 14A; Period of report 2024-12-11; Description PROXY STATEMENT; Document ea0224458-01.htm.
  • 2023-09-22: Form PRE 14A; Period of report 2023-09-22; Description PROXY STATEMENT; Document pre14a0923_tffpharma.htm.
  • 2022-12-15: Form PRE 14A; Period of report 2023-02-08; Description PRELIMINARY PROXY STATEMENT; Document ea170284-pre14a_tffpharma.htm.
FiledFormPeriod of reportDescriptionDocument
2024-12-11PRE 14A2024-12-11PROXY STATEMENTea0224458-01.htm
2023-09-22PRE 14A2023-09-22PROXY STATEMENTpre14a0923_tffpharma.htm
2022-12-15PRE 14A2023-02-08PRELIMINARY PROXY STATEMENTea170284-pre14a_tffpharma.htm